Skip to the page

Data / Form D filings / Sprout2 Inc.

Sprout2 Inc.: Form D filings

Sprout2 Inc., a pharmaceuticals company in Raleigh, NC, filed 8 Form D notices with the SEC between 2018 and 2024. The latest, on December 23, 2024, reports $10.6 million sold of a $12 million offering to 51 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4350 Lassiter at North Hills Ave., Suite 260, Raleigh, NC, 27609
Phone
(844) 746-5745
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1725755

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 23, 2024New notice$12,000,000$10,557,600$1,442,40051Dec 10, 2024sec.gov
Apr 14, 2023New notice$10,000,000$7,064,364$2,935,63643Mar 31, 2023sec.gov
Aug 15, 2022Amendment$30,000,000$27,969,129$2,030,87191Nov 25, 2020sec.gov
May 6, 2022Amendment$27,000,000$25,069,129$1,930,87185Nov 25, 2020sec.gov
Sep 15, 2021Amendment$18,700,000$12,396,129$6,303,87164Nov 25, 2020sec.gov
Dec 10, 2020New notice$10,000,000$8,126,129$1,873,87159Nov 25, 2020sec.gov
Aug 16, 2019New notice$20,000,000$15,900,000$4,100,000110Aug 2, 2019sec.gov
Jan 4, 2018New notice$6,600,000$4,500,000$2,100,000203Dec 20, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sandra Robert McGlothlinDirector
Margaret HenryExecutive Officer
W. Robert DahlDirector
Gail Robert BeckerDirector
Cynthia EckertExecutive Officer, Director
Robert WhiteheadDirector

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Dec 23, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Sprout2 Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.